The historical rank and industry rank for Concord Medical Services Holdings's Pretax Margin % or its related term are showing as below:
FRA:C2C'
s Pretax Margin % Range Over the Past 10 Years
Min: -198.04 Med: -113.49 Max: -44.96
Current: -80.98
FRA:C2C's Pretax Margin % is ranked worse than 89.16% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 4.01
vs FRA:C2C: -80.98
Concord Medical Services Holdings (FRA:C2C) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Concord Medical Services Holdings Pretax Margin % Related Terms
Concord Medical Services Holdings Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Concord Medical Services Holdings Pretax Margin % Chart
FRA:C2C vs CCEL, GBCS, CDIX: Pretax Margin % Comparison
For the Medical Care Facilities subindustry, Concord Medical Services Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Concord Medical Services Holdings Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Concord Medical Services Holdings's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Concord Medical Services Holdings's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Concord Medical Services Holdings (FRA:C2C) has a Pretax Margin % of -72.25% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Concord Medical Services Holdings and its competitors. According to the industry distribution chart, Concord Medical Services Holdings ranks #592 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 89.2%.
Is Concord Medical Services Holdings' Pretax Margin % too high?
Concord Medical Services Holdings' current Pretax Margin % is -72.25%. Based on the distribution chart, Concord Medical Services Holdings ranks #592 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Concord Medical Services Holdings has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Concord Medical Services Holdings' Pretax Margin % compare to CCEL and GBCS?
According to the Healthcare Providers & Services industry distribution chart, Concord Medical Services Holdings ranks #592 out of 664 companies for Pretax Margin %. This places Concord Medical Services Holdings in the lower half of its industry. The industry median Pretax Margin % is 4.01. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.01, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Concord Medical Services Holdings and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Concord Medical Services Holdings's current Pretax Margin % is -72.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Medical Services Holdings stock overvalued right now?
Concord Medical Services Holdings (FRA:C2C) has a current Pretax Margin % of -72.25%. The stock's GF Value™ is €9.81, compared to a current price of €6.25 — trading 36.3% below its estimated fair value. The current Pretax Margin % is -72.25%. Concord Medical Services Holdings' overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Concord Medical Services Holdings (FRA:C2C), the current Pretax Margin % is -72.25% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Concord Medical Services Holdings (FRA:C2C) Overvalued in 2026?
Based on GuruFocus' analysis, Concord Medical Services Holdings stock appears to be undervalued.
The current stock price of €6.25 is trading 36.3% below its estimated GF Value™ of €9.81.
Key valuation signals for FRA:C2C:
Pretax Margin %: -72.25%
GF Value™: €9.81 vs. price of €6.25 (36.3% below fair value)
No single metric tells the full story. See the FRA:C2C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Concord Medical Services Holdings Business Description
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.
51GF Score
Get the complete analysis for FRA:C2C
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:C2C has been successfully added to your 
